Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Hepatitis C virus quasispecies and pseudotype analysis from acute infection to chronicity in HIV-1 co-infected individuals.

Ferns RB, Tarr AW, Hue S, Urbanowicz RA, McClure CP, Gilson R, Ball JK, Nastouli E, Garson JA, Pillay D.

Virology. 2016 May;492:213-24. doi: 10.1016/j.virol.2016.02.003. Epub 2016 Mar 21.

2.

The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes targeted by cytotoxic T lymphocytes.

Erickson AL, Kimura Y, Igarashi S, Eichelberger J, Houghton M, Sidney J, McKinney D, Sette A, Hughes AL, Walker CM.

Immunity. 2001 Dec;15(6):883-95.

3.

Transmitted/Founder Viruses Rapidly Escape from CD8+ T Cell Responses in Acute Hepatitis C Virus Infection.

Bull RA, Leung P, Gaudieri S, Deshpande P, Cameron B, Walker M, Chopra A, Lloyd AR, Luciani F.

J Virol. 2015 May;89(10):5478-90. doi: 10.1128/JVI.03717-14. Epub 2015 Mar 4.

4.

CD4+ T-cell recovery with suppressive ART-induced rapid sequence evolution in hepatitis C virus envelope but not NS3.

Liu L, Nardo D, Li E, Wang GP.

AIDS. 2016 Mar 13;30(5):691-700. doi: 10.1097/QAD.0000000000000997.

5.

Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo.

von Hahn T, Yoon JC, Alter H, Rice CM, Rehermann B, Balfe P, McKeating JA.

Gastroenterology. 2007 Feb;132(2):667-78. Epub 2006 Dec 3.

PMID:
17258731
6.

The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies.

Farci P, Shimoda A, Coiana A, Diaz G, Peddis G, Melpolder JC, Strazzera A, Chien DY, Munoz SJ, Balestrieri A, Purcell RH, Alter HJ.

Science. 2000 Apr 14;288(5464):339-44.

7.

In vitro selection of a neutralization-resistant hepatitis C virus escape mutant.

Gal-Tanamy M, Keck ZY, Yi M, McKeating JA, Patel AH, Foung SK, Lemon SM.

Proc Natl Acad Sci U S A. 2008 Dec 9;105(49):19450-5. doi: 10.1073/pnas.0809879105. Epub 2008 Dec 3.

8.

Hepatitis C virus NS3/4A quasispecies diversity in acute hepatitis C infection in HIV-1 co-infected patients.

Nevot M, Boesecke C, Parera M, Andrés C, Franco S, Revollo B, Ingiliz P, Tural C, Clotet B, Rockstroh JK, Martinez MA; NEAT study group.

J Viral Hepat. 2014 Jun;21(6):e19-28. doi: 10.1111/jvh.12254. Epub 2014 Mar 27.

PMID:
24674023
9.

Relation between viral fitness and immune escape within the hepatitis C virus protease.

Söderholm J, Ahlén G, Kaul A, Frelin L, Alheim M, Barnfield C, Liljeström P, Weiland O, Milich DR, Bartenschlager R, Sällberg M.

Gut. 2006 Feb;55(2):266-74. Epub 2005 Aug 16.

10.

Naturally occurring CD4+ T-cell epitope variants act as altered peptide ligands leading to impaired helper T-cell responses in hepatitis C virus infection.

Cusick MF, Yang M, Gill JC, Eckels DD.

Hum Immunol. 2011 May;72(5):379-85. doi: 10.1016/j.humimm.2011.02.010. Epub 2011 Mar 4.

11.

HCV Specific IL-21 Producing T Cells but Not IL-17A Producing T Cells Are Associated with HCV Viral Control in HIV/HCV Coinfection.

MacParland SA, Fadel SM, Mihajlovic V, Fawaz A, Kim C, Rahman AK, Liu J, Kaul R, Kovacs C, Grebely J, Dore GJ, Wong DK, Ostrowski MA.

PLoS One. 2016 Apr 28;11(4):e0154433. doi: 10.1371/journal.pone.0154433. eCollection 2016.

12.

Trends for genetic variation of Hepatitis C Virus quasispecies in Human Immunodeficiency virus-1 coinfected patients.

López-Labrador FX, Dove L, Hui CK, Phung Y, Kim M, Berenguer M, Wright TL.

Virus Res. 2007 Dec;130(1-2):285-91. Epub 2007 Jun 29.

13.

Genetic variability of hepatitis C virus in chronically infected patients with viral breakthrough during interferon-ribavirin therapy.

Vuillermoz I, Khattab E, Sablon E, Ottevaere I, Durantel D, Vieux C, Trepo C, Zoulim F.

J Med Virol. 2004 Sep;74(1):41-53.

PMID:
15258967
14.

Evolution and function of the HCV NS3 protease in patients with acute hepatitis C and HIV coinfection.

Dietz J, Lutz T, Knecht G, Gute P, Berkowski C, Lange CM, Khaykin P, Stephan C, Brodt HR, Herrmann E, Zeuzem S, Sarrazin C.

Virology. 2015 Nov;485:213-22. doi: 10.1016/j.virol.2015.06.030. Epub 2015 Aug 25.

15.

Neutralizing antibodies and pathogenesis of hepatitis C virus infection.

Fafi-Kremer S, Fauvelle C, Felmlee DJ, Zeisel MB, Lepiller Q, Fofana I, Heydmann L, Stoll-Keller F, Baumert TF.

Viruses. 2012 Oct 9;4(10):2016-30. doi: 10.3390/v4102016. Review.

16.

Limited naturally occurring escape in broadly neutralizing antibody epitopes in hepatitis C glycoprotein E2 and constrained sequence usage in acute infection.

Rodrigo C, Walker MR, Leung P, Eltahla AA, Grebely J, Dore GJ, Applegate T, Page K, Dwivedi S, Bruneau J, Morris MD, Cox AL, Osburn W, Kim AY, Schinkel J, Shoukry NH, Lauer GM, Maher L, Hellard M, Prins M, Luciani F, Lloyd AR, Bull RA; InC(3) Study Group.

Infect Genet Evol. 2017 Apr;49:88-96. doi: 10.1016/j.meegid.2017.01.006. Epub 2017 Jan 5.

17.

Genetic variability of hepatitis C virus non-structural protein 3 and virus-specific CD8+ response in patients with chronic hepatitis C.

López-Labrador FX, He XS, Berenguer M, Cheung RC, González-Candelas F, Wright TL, Greenberg HB.

J Med Virol. 2004 Apr;72(4):575-85.

PMID:
14981760
18.

Immune selection and genetic sequence variation in core and envelope regions of hepatitis C virus.

Christie JM, Chapel H, Chapman RW, Rosenberg WM.

Hepatology. 1999 Oct;30(4):1037-44.

PMID:
10498657
19.

Previous failure of interferon-based therapy does not alter the frequency of HCV NS3 protease or NS5B polymerase inhibitor resistance-associated variants: longitudinal analysis in HCV/HIV co-infected patients.

Sede MM, Laufer NL, Quarleri J.

Int J Antimicrob Agents. 2015 Aug;46(2):219-24. doi: 10.1016/j.ijantimicag.2015.04.011. Epub 2015 Jun 4.

PMID:
26100213
20.

Characterization of humoral and cell-mediated immune responses directed against hepatitis C virus F protein in subjects co-infected with hepatitis C virus and HIV-1.

Troesch M, Jalbert E, Canobio S, Boulassel MR, Routy JP, Bernard NF, Bruneau J, Lapointe N, Boucher M, Soudeyns H.

AIDS. 2005 May 20;19(8):775-84.

PMID:
15867491

Supplemental Content

Support Center